nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—kidney cancer—vaginal cancer	0.784	1	CtDrD
Sunitinib—MAP3K7—Toll-like Receptor Signaling Pathway—IFNA1—vaginal cancer	0.000299	0.00605	CbGpPWpGaD
Sunitinib—PAK3—Immune System—EIF4A3—vaginal cancer	0.000293	0.00593	CbGpPWpGaD
Sunitinib—PTK2B—IL2-mediated signaling events—IL2—vaginal cancer	0.000293	0.00593	CbGpPWpGaD
Sunitinib—FYN—Cytokine Signaling in Immune system—EIF4A3—vaginal cancer	0.000293	0.00593	CbGpPWpGaD
Sunitinib—MAP2K1—Cytokine Signaling in Immune system—EIF4A3—vaginal cancer	0.000291	0.0059	CbGpPWpGaD
Sunitinib—JAK2—IL27-mediated signaling events—IL2—vaginal cancer	0.000288	0.00583	CbGpPWpGaD
Sunitinib—TYK2—IL23-mediated signaling events—IL2—vaginal cancer	0.000287	0.0058	CbGpPWpGaD
Sunitinib—JAK2—Cytokine Signaling in Immune system—EIF4A3—vaginal cancer	0.000278	0.00563	CbGpPWpGaD
Sunitinib—FYN—T-Cell Receptor and Co-stimulatory Signaling—IL2—vaginal cancer	0.000278	0.00562	CbGpPWpGaD
Sunitinib—JAK2—Interleukin receptor SHC signaling—IL2—vaginal cancer	0.000272	0.0055	CbGpPWpGaD
Sunitinib—YES1—Interleukin-3, 5 and GM-CSF signaling—IL2—vaginal cancer	0.000271	0.00549	CbGpPWpGaD
Sunitinib—NTRK1—SHP2 signaling—IL2—vaginal cancer	0.000265	0.00536	CbGpPWpGaD
Sunitinib—MAP2K2—Toll-like Receptor Signaling Pathway—IFNA1—vaginal cancer	0.000261	0.00528	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—EIF4A3—vaginal cancer	0.000256	0.00518	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—EIF4A3—vaginal cancer	0.000253	0.00512	CbGpPWpGaD
Sunitinib—KDR—SHP2 signaling—IL2—vaginal cancer	0.00025	0.00507	CbGpPWpGaD
Sunitinib—IRAK1—Regulation of toll-like receptor signaling pathway—IFNA1—vaginal cancer	0.000248	0.00501	CbGpPWpGaD
Sunitinib—MAP2K1—Toll-like Receptor Signaling Pathway—IFNA1—vaginal cancer	0.000244	0.00494	CbGpPWpGaD
Sunitinib—ULK3—mammalian vulva—vaginal cancer	0.000244	0.00146	CbGeAlD
Sunitinib—TYK2—endometrium—vaginal cancer	0.000244	0.00146	CbGeAlD
Sunitinib—STK3—female gonad—vaginal cancer	0.000242	0.00145	CbGeAlD
Sunitinib—FLT3—female reproductive system—vaginal cancer	0.000242	0.00145	CbGeAlD
Sunitinib—MAP3K12—female reproductive system—vaginal cancer	0.000242	0.00145	CbGeAlD
Sunitinib—FYN—uterine cervix—vaginal cancer	0.000242	0.00145	CbGeAlD
Sunitinib—CSNK1E—uterus—vaginal cancer	0.000242	0.00145	CbGeAlD
Sunitinib—FGFR1—uterus—vaginal cancer	0.000242	0.00145	CbGeAlD
Sunitinib—STK3—vagina—vaginal cancer	0.000241	0.00144	CbGeAlD
Sunitinib—MAP3K7—mammalian vulva—vaginal cancer	0.00024	0.00144	CbGeAlD
Sunitinib—RPS6KB1—urethra—vaginal cancer	0.00024	0.00144	CbGeAlD
Sunitinib—ROCK1—female gonad—vaginal cancer	0.000239	0.00143	CbGeAlD
Sunitinib—RPS6KA3—female reproductive system—vaginal cancer	0.000239	0.00143	CbGeAlD
Sunitinib—FGR—urethra—vaginal cancer	0.000238	0.00143	CbGeAlD
Sunitinib—MAP2K1—female reproductive system—vaginal cancer	0.000237	0.00142	CbGeAlD
Sunitinib—AXL—urethra—vaginal cancer	0.000237	0.00142	CbGeAlD
Sunitinib—TBK1—mammalian vulva—vaginal cancer	0.000237	0.00142	CbGeAlD
Sunitinib—TYK2—Interleukin-2 signaling—IL2—vaginal cancer	0.000237	0.00479	CbGpPWpGaD
Sunitinib—MAP4K5—uterine cervix—vaginal cancer	0.000236	0.00141	CbGeAlD
Sunitinib—MAP3K3—uterine cervix—vaginal cancer	0.000236	0.00141	CbGeAlD
Sunitinib—RPS6KB1—endometrium—vaginal cancer	0.000236	0.00141	CbGeAlD
Sunitinib—TYK2—mammalian vulva—vaginal cancer	0.000236	0.00141	CbGeAlD
Sunitinib—CAMK2G—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000235	0.00475	CbGpPWpGaD
Sunitinib—FGR—endometrium—vaginal cancer	0.000235	0.0014	CbGeAlD
Sunitinib—CSNK1A1—female reproductive system—vaginal cancer	0.000234	0.0014	CbGeAlD
Sunitinib—AXL—endometrium—vaginal cancer	0.000234	0.0014	CbGeAlD
Sunitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—IFNA1—vaginal cancer	0.000233	0.00472	CbGpPWpGaD
Sunitinib—DYRK1A—female gonad—vaginal cancer	0.000233	0.0014	CbGeAlD
Sunitinib—CLK1—female reproductive system—vaginal cancer	0.000233	0.00139	CbGeAlD
Sunitinib—IRAK1—mammalian vulva—vaginal cancer	0.000233	0.00139	CbGeAlD
Sunitinib—ULK3—uterus—vaginal cancer	0.000233	0.00139	CbGeAlD
Sunitinib—MAP2K2—uterus—vaginal cancer	0.000233	0.00139	CbGeAlD
Sunitinib—MAP3K2—uterus—vaginal cancer	0.000231	0.00138	CbGeAlD
Sunitinib—FLT1—epithelium—vaginal cancer	0.00023	0.00138	CbGeAlD
Sunitinib—MAP3K3—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000229	0.00464	CbGpPWpGaD
Sunitinib—MAP3K7—uterus—vaginal cancer	0.000229	0.00137	CbGeAlD
Sunitinib—BMP2K—female reproductive system—vaginal cancer	0.000229	0.00137	CbGeAlD
Sunitinib—CAMK2G—female reproductive system—vaginal cancer	0.000229	0.00137	CbGeAlD
Sunitinib—SLK—urethra—vaginal cancer	0.000229	0.00137	CbGeAlD
Sunitinib—FLT1—uterine cervix—vaginal cancer	0.000228	0.00137	CbGeAlD
Sunitinib—MAP2K2—IL-5 Signaling Pathway—IL2—vaginal cancer	0.000228	0.00462	CbGpPWpGaD
Sunitinib—RPS6KB1—mammalian vulva—vaginal cancer	0.000228	0.00137	CbGeAlD
Sunitinib—MERTK—female gonad—vaginal cancer	0.000228	0.00136	CbGeAlD
Sunitinib—RPS6KA1—Immune System—EIF4A3—vaginal cancer	0.000227	0.0046	CbGpPWpGaD
Sunitinib—FGR—mammalian vulva—vaginal cancer	0.000227	0.00136	CbGeAlD
Sunitinib—MERTK—vagina—vaginal cancer	0.000227	0.00136	CbGeAlD
Sunitinib—LRRK2—female reproductive system—vaginal cancer	0.000226	0.00136	CbGeAlD
Sunitinib—RPS6KB1—Regulation of Telomerase—IL2—vaginal cancer	0.000226	0.00458	CbGpPWpGaD
Sunitinib—AXL—mammalian vulva—vaginal cancer	0.000226	0.00135	CbGeAlD
Sunitinib—EPHB6—uterine cervix—vaginal cancer	0.000226	0.00135	CbGeAlD
Sunitinib—JAK2—urethra—vaginal cancer	0.000225	0.00135	CbGeAlD
Sunitinib—SLK—endometrium—vaginal cancer	0.000225	0.00135	CbGeAlD
Sunitinib—TYK2—uterus—vaginal cancer	0.000225	0.00134	CbGeAlD
Sunitinib—MAP4K4—female gonad—vaginal cancer	0.000224	0.00134	CbGeAlD
Sunitinib—PRKAA1—female reproductive system—vaginal cancer	0.000223	0.00134	CbGeAlD
Sunitinib—MAP4K4—vagina—vaginal cancer	0.000222	0.00133	CbGeAlD
Sunitinib—FYN—urethra—vaginal cancer	0.000222	0.00133	CbGeAlD
Sunitinib—NUAK2—female gonad—vaginal cancer	0.000222	0.00133	CbGeAlD
Sunitinib—JAK2—endometrium—vaginal cancer	0.000222	0.00133	CbGeAlD
Sunitinib—NUAK2—vagina—vaginal cancer	0.000221	0.00132	CbGeAlD
Sunitinib—PTK2B—female reproductive system—vaginal cancer	0.000221	0.00132	CbGeAlD
Sunitinib—FLT3—female gonad—vaginal cancer	0.000221	0.00132	CbGeAlD
Sunitinib—MAP3K12—female gonad—vaginal cancer	0.000221	0.00132	CbGeAlD
Sunitinib—FLT4—female reproductive system—vaginal cancer	0.00022	0.00132	CbGeAlD
Sunitinib—MAP2K2—IL-2 Signaling Pathway—IL2—vaginal cancer	0.00022	0.00444	CbGpPWpGaD
Sunitinib—MAP3K12—vagina—vaginal cancer	0.000219	0.00131	CbGeAlD
Sunitinib—FYN—endometrium—vaginal cancer	0.000219	0.00131	CbGeAlD
Sunitinib—YES1—uterine cervix—vaginal cancer	0.000218	0.00131	CbGeAlD
Sunitinib—SLK—mammalian vulva—vaginal cancer	0.000218	0.0013	CbGeAlD
Sunitinib—RPS6KA3—female gonad—vaginal cancer	0.000217	0.0013	CbGeAlD
Sunitinib—JAK2—IL23-mediated signaling events—IL2—vaginal cancer	0.000217	0.0044	CbGpPWpGaD
Sunitinib—CSNK1E—female reproductive system—vaginal cancer	0.000217	0.0013	CbGeAlD
Sunitinib—MAP3K3—urethra—vaginal cancer	0.000217	0.0013	CbGeAlD
Sunitinib—MAP4K5—urethra—vaginal cancer	0.000217	0.0013	CbGeAlD
Sunitinib—STK10—uterine cervix—vaginal cancer	0.000216	0.00129	CbGeAlD
Sunitinib—RPS6KA3—vagina—vaginal cancer	0.000216	0.00129	CbGeAlD
Sunitinib—MAP2K1—female gonad—vaginal cancer	0.000216	0.00129	CbGeAlD
Sunitinib—TAOK3—uterine cervix—vaginal cancer	0.000215	0.00129	CbGeAlD
Sunitinib—AXL—uterus—vaginal cancer	0.000215	0.00129	CbGeAlD
Sunitinib—JAK2—mammalian vulva—vaginal cancer	0.000214	0.00128	CbGeAlD
Sunitinib—MAP2K1—IL-5 Signaling Pathway—IL2—vaginal cancer	0.000214	0.00432	CbGpPWpGaD
Sunitinib—MAP4K5—endometrium—vaginal cancer	0.000214	0.00128	CbGeAlD
Sunitinib—MAP3K3—endometrium—vaginal cancer	0.000214	0.00128	CbGeAlD
Sunitinib—CSNK1A1—female gonad—vaginal cancer	0.000213	0.00128	CbGeAlD
Sunitinib—IRAK4—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000213	0.00431	CbGpPWpGaD
Sunitinib—CSNK1A1—vagina—vaginal cancer	0.000212	0.00127	CbGeAlD
Sunitinib—CLK1—female gonad—vaginal cancer	0.000212	0.00127	CbGeAlD
Sunitinib—FYN—mammalian vulva—vaginal cancer	0.000212	0.00127	CbGeAlD
Sunitinib—CLK1—vagina—vaginal cancer	0.000211	0.00126	CbGeAlD
Sunitinib—FLT1—urethra—vaginal cancer	0.00021	0.00126	CbGeAlD
Sunitinib—ULK3—female reproductive system—vaginal cancer	0.000209	0.00125	CbGeAlD
Sunitinib—MAP2K2—female reproductive system—vaginal cancer	0.000209	0.00125	CbGeAlD
Sunitinib—TBK1—Immune System—EIF4A3—vaginal cancer	0.000209	0.00423	CbGpPWpGaD
Sunitinib—CAMK2G—female gonad—vaginal cancer	0.000208	0.00125	CbGeAlD
Sunitinib—BMP2K—female gonad—vaginal cancer	0.000208	0.00125	CbGeAlD
Sunitinib—MAP3K2—female reproductive system—vaginal cancer	0.000208	0.00124	CbGeAlD
Sunitinib—EPHB6—urethra—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—SLK—uterus—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—MAP3K3—mammalian vulva—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—MAP4K5—mammalian vulva—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—CAMK2G—vagina—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—BMP2K—vagina—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—FYN—IL-2 Signaling Pathway—IL2—vaginal cancer	0.000207	0.00418	CbGpPWpGaD
Sunitinib—FLT1—endometrium—vaginal cancer	0.000207	0.00124	CbGeAlD
Sunitinib—LRRK2—female gonad—vaginal cancer	0.000206	0.00123	CbGeAlD
Sunitinib—TYK2—Interferon Signaling—IFNA1—vaginal cancer	0.000206	0.00416	CbGpPWpGaD
Sunitinib—MAP2K1—IL-2 Signaling Pathway—IL2—vaginal cancer	0.000206	0.00416	CbGpPWpGaD
Sunitinib—FGFR2—uterus—vaginal cancer	0.000205	0.00123	CbGeAlD
Sunitinib—CAMK2G—Immune System—EIF4A3—vaginal cancer	0.000205	0.00415	CbGpPWpGaD
Sunitinib—LRRK2—vagina—vaginal cancer	0.000205	0.00123	CbGeAlD
Sunitinib—JAK2—IL-5 Signaling Pathway—IL2—vaginal cancer	0.000204	0.00413	CbGpPWpGaD
Sunitinib—EPHB6—endometrium—vaginal cancer	0.000204	0.00122	CbGeAlD
Sunitinib—MAP2K2—Regulation of toll-like receptor signaling pathway—IFNA1—vaginal cancer	0.000204	0.00413	CbGpPWpGaD
Sunitinib—TBK1—female reproductive system—vaginal cancer	0.000203	0.00122	CbGeAlD
Sunitinib—MAP3K3—Signaling by Interleukins—IL2—vaginal cancer	0.000203	0.00411	CbGpPWpGaD
Sunitinib—PRKAA1—female gonad—vaginal cancer	0.000203	0.00122	CbGeAlD
Sunitinib—TYK2—female reproductive system—vaginal cancer	0.000202	0.00121	CbGeAlD
Sunitinib—FYN—uterus—vaginal cancer	0.000202	0.00121	CbGeAlD
Sunitinib—PTK2B—female gonad—vaginal cancer	0.000201	0.0012	CbGeAlD
Sunitinib—MAP2K2—Interleukin-2 signaling—IL2—vaginal cancer	0.000201	0.00406	CbGpPWpGaD
Sunitinib—YES1—urethra—vaginal cancer	0.000201	0.0012	CbGeAlD
Sunitinib—MAP3K3—Immune System—EIF4A3—vaginal cancer	0.0002	0.00405	CbGpPWpGaD
Sunitinib—FLT4—female gonad—vaginal cancer	0.0002	0.0012	CbGeAlD
Sunitinib—FLT1—mammalian vulva—vaginal cancer	0.0002	0.0012	CbGeAlD
Sunitinib—PTK2B—vagina—vaginal cancer	0.0002	0.0012	CbGeAlD
Sunitinib—IRAK1—female reproductive system—vaginal cancer	0.000199	0.00119	CbGeAlD
Sunitinib—FYN—Interleukin-3, 5 and GM-CSF signaling—IL2—vaginal cancer	0.000199	0.00403	CbGpPWpGaD
Sunitinib—TAOK3—urethra—vaginal cancer	0.000198	0.00119	CbGeAlD
Sunitinib—CSNK1E—female gonad—vaginal cancer	0.000198	0.00118	CbGeAlD
Sunitinib—FGFR1—female gonad—vaginal cancer	0.000198	0.00118	CbGeAlD
Sunitinib—EPHB6—mammalian vulva—vaginal cancer	0.000198	0.00118	CbGeAlD
Sunitinib—YES1—endometrium—vaginal cancer	0.000197	0.00118	CbGeAlD
Sunitinib—ITK—Innate Immune System—IFNA1—vaginal cancer	0.000197	0.00399	CbGpPWpGaD
Sunitinib—MAP4K5—uterus—vaginal cancer	0.000197	0.00118	CbGeAlD
Sunitinib—CSNK1E—vagina—vaginal cancer	0.000196	0.00118	CbGeAlD
Sunitinib—FGFR1—vagina—vaginal cancer	0.000196	0.00118	CbGeAlD
Sunitinib—RPS6KB1—female reproductive system—vaginal cancer	0.000196	0.00117	CbGeAlD
Sunitinib—TYK2—IL12-mediated signaling events—IL2—vaginal cancer	0.000195	0.00394	CbGpPWpGaD
Sunitinib—TAOK3—endometrium—vaginal cancer	0.000195	0.00117	CbGeAlD
Sunitinib—KDR—epithelium—vaginal cancer	0.000195	0.00117	CbGeAlD
Sunitinib—IRAK4—female gonad—vaginal cancer	0.000195	0.00116	CbGeAlD
Sunitinib—FGR—female reproductive system—vaginal cancer	0.000194	0.00116	CbGeAlD
Sunitinib—AXL—female reproductive system—vaginal cancer	0.000194	0.00116	CbGeAlD
Sunitinib—IRAK4—vagina—vaginal cancer	0.000193	0.00116	CbGeAlD
Sunitinib—KDR—uterine cervix—vaginal cancer	0.000193	0.00116	CbGeAlD
Sunitinib—MAP2K5—uterine cervix—vaginal cancer	0.000193	0.00116	CbGeAlD
Sunitinib—YES1—mammalian vulva—vaginal cancer	0.000191	0.00114	CbGeAlD
Sunitinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IFNA1—vaginal cancer	0.000191	0.00386	CbGpPWpGaD
Sunitinib—FLT1—uterus—vaginal cancer	0.00019	0.00114	CbGeAlD
Sunitinib—ULK3—female gonad—vaginal cancer	0.00019	0.00114	CbGeAlD
Sunitinib—MAP2K2—female gonad—vaginal cancer	0.00019	0.00114	CbGeAlD
Sunitinib—PTK2B—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.00019	0.00384	CbGpPWpGaD
Sunitinib—JAK2—Interleukin-3, 5 and GM-CSF signaling—IL2—vaginal cancer	0.000189	0.00383	CbGpPWpGaD
Sunitinib—STK10—mammalian vulva—vaginal cancer	0.000189	0.00113	CbGeAlD
Sunitinib—ULK3—vagina—vaginal cancer	0.000189	0.00113	CbGeAlD
Sunitinib—IRAK4—Signaling by Interleukins—IL2—vaginal cancer	0.000189	0.00382	CbGpPWpGaD
Sunitinib—MAP3K2—female gonad—vaginal cancer	0.000189	0.00113	CbGeAlD
Sunitinib—TAOK3—mammalian vulva—vaginal cancer	0.000188	0.00113	CbGeAlD
Sunitinib—CSF1R—uterine cervix—vaginal cancer	0.000188	0.00113	CbGeAlD
Sunitinib—PAK3—Innate Immune System—IFNA1—vaginal cancer	0.000188	0.00381	CbGpPWpGaD
Sunitinib—MAP2K1—Interleukin-2 signaling—IL2—vaginal cancer	0.000188	0.0038	CbGpPWpGaD
Sunitinib—MAP3K7—female gonad—vaginal cancer	0.000187	0.00112	CbGeAlD
Sunitinib—IRAK4—Immune System—EIF4A3—vaginal cancer	0.000186	0.00377	CbGpPWpGaD
Sunitinib—MAP3K7—vagina—vaginal cancer	0.000186	0.00111	CbGeAlD
Sunitinib—JAK2—Factors involved in megakaryocyte development and platelet production—IFNA1—vaginal cancer	0.000186	0.00375	CbGpPWpGaD
Sunitinib—TBK1—female gonad—vaginal cancer	0.000185	0.00111	CbGeAlD
Sunitinib—FGFR2—female reproductive system—vaginal cancer	0.000185	0.00111	CbGeAlD
Sunitinib—TBK1—vagina—vaginal cancer	0.000184	0.0011	CbGeAlD
Sunitinib—TYK2—female gonad—vaginal cancer	0.000184	0.0011	CbGeAlD
Sunitinib—JAK2—female reproductive system—vaginal cancer	0.000184	0.0011	CbGeAlD
Sunitinib—FYN—GPVI-mediated activation cascade—IL2—vaginal cancer	0.000183	0.0037	CbGpPWpGaD
Sunitinib—TYK2—vagina—vaginal cancer	0.000183	0.00109	CbGeAlD
Sunitinib—YES1—uterus—vaginal cancer	0.000182	0.00109	CbGeAlD
Sunitinib—IRAK1—female gonad—vaginal cancer	0.000181	0.00109	CbGeAlD
Sunitinib—RPS6KA3—Immune System—EIF4A3—vaginal cancer	0.000181	0.00367	CbGpPWpGaD
Sunitinib—FYN—female reproductive system—vaginal cancer	0.000181	0.00108	CbGeAlD
Sunitinib—STK10—uterus—vaginal cancer	0.00018	0.00108	CbGeAlD
Sunitinib—MAP2K2—IL2-mediated signaling events—IL2—vaginal cancer	0.00018	0.00363	CbGpPWpGaD
Sunitinib—TAOK3—uterus—vaginal cancer	0.00018	0.00108	CbGeAlD
Sunitinib—JAK2—Interleukin-2 signaling—IL2—vaginal cancer	0.00018	0.00363	CbGpPWpGaD
Sunitinib—PDGFRA—uterus—vaginal cancer	0.000178	0.00107	CbGeAlD
Sunitinib—RPS6KB1—female gonad—vaginal cancer	0.000178	0.00107	CbGeAlD
Sunitinib—MAP2K5—urethra—vaginal cancer	0.000177	0.00106	CbGeAlD
Sunitinib—KDR—urethra—vaginal cancer	0.000177	0.00106	CbGeAlD
Sunitinib—MAP3K3—female reproductive system—vaginal cancer	0.000177	0.00106	CbGeAlD
Sunitinib—MAP4K5—female reproductive system—vaginal cancer	0.000177	0.00106	CbGeAlD
Sunitinib—RPS6KB1—vagina—vaginal cancer	0.000177	0.00106	CbGeAlD
Sunitinib—FGR—female gonad—vaginal cancer	0.000177	0.00106	CbGeAlD
Sunitinib—JAK2—G beta:gamma signalling through PI3Kgamma—IL2—vaginal cancer	0.000177	0.00357	CbGpPWpGaD
Sunitinib—AXL—female gonad—vaginal cancer	0.000176	0.00105	CbGeAlD
Sunitinib—FGR—vagina—vaginal cancer	0.000176	0.00105	CbGeAlD
Sunitinib—AXL—vagina—vaginal cancer	0.000175	0.00105	CbGeAlD
Sunitinib—KDR—endometrium—vaginal cancer	0.000175	0.00105	CbGeAlD
Sunitinib—MAP2K5—endometrium—vaginal cancer	0.000175	0.00105	CbGeAlD
Sunitinib—JAK2—GPVI-mediated activation cascade—IL2—vaginal cancer	0.000174	0.00351	CbGpPWpGaD
Sunitinib—CSF1R—urethra—vaginal cancer	0.000173	0.00104	CbGeAlD
Sunitinib—KIT—epithelium—vaginal cancer	0.000173	0.00103	CbGeAlD
Sunitinib—FLT1—female reproductive system—vaginal cancer	0.000171	0.00102	CbGeAlD
Sunitinib—KIT—uterine cervix—vaginal cancer	0.000171	0.00102	CbGeAlD
Sunitinib—CSF1R—endometrium—vaginal cancer	0.00017	0.00102	CbGeAlD
Sunitinib—MAP2K2—SHP2 signaling—IL2—vaginal cancer	0.00017	0.00343	CbGpPWpGaD
Sunitinib—SLK—female gonad—vaginal cancer	0.00017	0.00102	CbGeAlD
Sunitinib—FYN—IL2-mediated signaling events—IL2—vaginal cancer	0.000169	0.00342	CbGpPWpGaD
Sunitinib—KDR—mammalian vulva—vaginal cancer	0.000169	0.00101	CbGeAlD
Sunitinib—MAP2K5—mammalian vulva—vaginal cancer	0.000169	0.00101	CbGeAlD
Sunitinib—PDGFRB—epithelium—vaginal cancer	0.000169	0.00101	CbGeAlD
Sunitinib—SLK—vagina—vaginal cancer	0.000168	0.00101	CbGeAlD
Sunitinib—PTK2B—Signaling by Interleukins—IL2—vaginal cancer	0.000168	0.00341	CbGpPWpGaD
Sunitinib—JAK2—G-protein beta:gamma signalling—IL2—vaginal cancer	0.000168	0.0034	CbGpPWpGaD
Sunitinib—MAP2K1—IL2-mediated signaling events—IL2—vaginal cancer	0.000168	0.0034	CbGpPWpGaD
Sunitinib—FGFR2—female gonad—vaginal cancer	0.000168	0.00101	CbGeAlD
Sunitinib—PDGFRB—uterine cervix—vaginal cancer	0.000167	0.001	CbGeAlD
Sunitinib—JAK2—female gonad—vaginal cancer	0.000167	0.001	CbGeAlD
Sunitinib—JAK2—vagina—vaginal cancer	0.000166	0.000995	CbGeAlD
Sunitinib—PTK2B—Immune System—EIF4A3—vaginal cancer	0.000166	0.00336	CbGpPWpGaD
Sunitinib—PDGFRB—SHP2 signaling—IL2—vaginal cancer	0.000166	0.00335	CbGpPWpGaD
Sunitinib—CSF1R—mammalian vulva—vaginal cancer	0.000165	0.000987	CbGeAlD
Sunitinib—FYN—female gonad—vaginal cancer	0.000165	0.000987	CbGeAlD
Sunitinib—RPS6KA5—Innate Immune System—IFNA1—vaginal cancer	0.000164	0.00332	CbGpPWpGaD
Sunitinib—FYN—vagina—vaginal cancer	0.000164	0.000981	CbGeAlD
Sunitinib—YES1—female reproductive system—vaginal cancer	0.000163	0.000979	CbGeAlD
Sunitinib—RPS6KA2—Innate Immune System—IFNA1—vaginal cancer	0.000163	0.00329	CbGpPWpGaD
Sunitinib—BLK—Immune System—EIF4A3—vaginal cancer	0.000162	0.00328	CbGpPWpGaD
Sunitinib—STK10—female reproductive system—vaginal cancer	0.000162	0.00097	CbGeAlD
Sunitinib—FGR—Immune System—EIF4A3—vaginal cancer	0.000161	0.00327	CbGpPWpGaD
Sunitinib—TAOK3—female reproductive system—vaginal cancer	0.000161	0.000967	CbGeAlD
Sunitinib—MAP4K5—female gonad—vaginal cancer	0.000161	0.000965	CbGeAlD
Sunitinib—MAP3K3—female gonad—vaginal cancer	0.000161	0.000965	CbGeAlD
Sunitinib—KDR—uterus—vaginal cancer	0.000161	0.000964	CbGeAlD
Sunitinib—PDGFRA—female reproductive system—vaginal cancer	0.00016	0.00096	CbGeAlD
Sunitinib—MAP4K5—vagina—vaginal cancer	0.00016	0.000959	CbGeAlD
Sunitinib—MAP3K3—vagina—vaginal cancer	0.00016	0.000959	CbGeAlD
Sunitinib—MAP2K1—SHP2 signaling—IL2—vaginal cancer	0.000159	0.00321	CbGpPWpGaD
Sunitinib—MERTK—Hemostasis—IL2—vaginal cancer	0.000158	0.00319	CbGpPWpGaD
Sunitinib—KIT—urethra—vaginal cancer	0.000157	0.000942	CbGeAlD
Sunitinib—CSF1R—uterus—vaginal cancer	0.000157	0.000941	CbGeAlD
Sunitinib—JAK2—Interferon Signaling—IFNA1—vaginal cancer	0.000156	0.00315	CbGpPWpGaD
Sunitinib—FLT1—female gonad—vaginal cancer	0.000156	0.000933	CbGeAlD
Sunitinib—FLT1—vagina—vaginal cancer	0.000155	0.000927	CbGeAlD
Sunitinib—KIT—endometrium—vaginal cancer	0.000155	0.000927	CbGeAlD
Sunitinib—EPHB6—female gonad—vaginal cancer	0.000154	0.000922	CbGeAlD
Sunitinib—PDGFRB—urethra—vaginal cancer	0.000154	0.00092	CbGeAlD
Sunitinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—IL2—vaginal cancer	0.000153	0.0031	CbGpPWpGaD
Sunitinib—EPHB6—vagina—vaginal cancer	0.000153	0.000916	CbGeAlD
Sunitinib—JAK2—SHP2 signaling—IL2—vaginal cancer	0.000152	0.00307	CbGpPWpGaD
Sunitinib—PDGFRB—endometrium—vaginal cancer	0.000151	0.000905	CbGeAlD
Sunitinib—KIT—mammalian vulva—vaginal cancer	0.00015	0.000897	CbGeAlD
Sunitinib—YES1—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000149	0.00302	CbGpPWpGaD
Sunitinib—YES1—female gonad—vaginal cancer	0.000149	0.000891	CbGeAlD
Sunitinib—YES1—vagina—vaginal cancer	0.000148	0.000885	CbGeAlD
Sunitinib—JAK2—IL12-mediated signaling events—IL2—vaginal cancer	0.000148	0.00299	CbGpPWpGaD
Sunitinib—STK10—female gonad—vaginal cancer	0.000147	0.000883	CbGeAlD
Sunitinib—TAOK3—female gonad—vaginal cancer	0.000147	0.000879	CbGeAlD
Sunitinib—STK10—vagina—vaginal cancer	0.000147	0.000877	CbGeAlD
Sunitinib—PDGFRB—mammalian vulva—vaginal cancer	0.000146	0.000876	CbGeAlD
Sunitinib—RPS6KA1—Innate Immune System—IFNA1—vaginal cancer	0.000146	0.00295	CbGpPWpGaD
Sunitinib—TAOK3—vagina—vaginal cancer	0.000146	0.000874	CbGeAlD
Sunitinib—PDGFRA—female gonad—vaginal cancer	0.000146	0.000874	CbGeAlD
Sunitinib—PDGFRA—vagina—vaginal cancer	0.000145	0.000869	CbGeAlD
Sunitinib—KDR—female reproductive system—vaginal cancer	0.000145	0.000866	CbGeAlD
Sunitinib—MAP2K5—female reproductive system—vaginal cancer	0.000145	0.000866	CbGeAlD
Sunitinib—PDGFRA—Allograft Rejection—IL2—vaginal cancer	0.000144	0.0029	CbGpPWpGaD
Sunitinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—IL2—vaginal cancer	0.000143	0.0029	CbGpPWpGaD
Sunitinib—KIT—uterus—vaginal cancer	0.000143	0.000854	CbGeAlD
Sunitinib—IRAK1—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000142	0.00286	CbGpPWpGaD
Sunitinib—CSF1R—female reproductive system—vaginal cancer	0.000141	0.000846	CbGeAlD
Sunitinib—PDGFRB—uterus—vaginal cancer	0.000139	0.000834	CbGeAlD
Sunitinib—TYK2—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000137	0.00278	CbGpPWpGaD
Sunitinib—TBK1—Innate Immune System—IFNA1—vaginal cancer	0.000134	0.00271	CbGpPWpGaD
Sunitinib—MAP3K7—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000133	0.0027	CbGpPWpGaD
Sunitinib—YES1—Signaling by Interleukins—IL2—vaginal cancer	0.000132	0.00268	CbGpPWpGaD
Sunitinib—KDR—female gonad—vaginal cancer	0.000132	0.000788	CbGeAlD
Sunitinib—MAP2K5—female gonad—vaginal cancer	0.000132	0.000788	CbGeAlD
Sunitinib—KDR—vagina—vaginal cancer	0.000131	0.000784	CbGeAlD
Sunitinib—MAP2K5—vagina—vaginal cancer	0.000131	0.000784	CbGeAlD
Sunitinib—YES1—Immune System—EIF4A3—vaginal cancer	0.00013	0.00264	CbGpPWpGaD
Sunitinib—CSF1R—female gonad—vaginal cancer	0.000128	0.000769	CbGeAlD
Sunitinib—KIT—female reproductive system—vaginal cancer	0.000128	0.000768	CbGeAlD
Sunitinib—CSF1R—vagina—vaginal cancer	0.000128	0.000765	CbGeAlD
Sunitinib—IRAK1—Signaling by Interleukins—IL2—vaginal cancer	0.000125	0.00254	CbGpPWpGaD
Sunitinib—PDGFRB—female reproductive system—vaginal cancer	0.000125	0.00075	CbGeAlD
Sunitinib—IRAK1—Immune System—EIF4A3—vaginal cancer	0.000124	0.0025	CbGpPWpGaD
Sunitinib—TYK2—Signaling by Interleukins—IL2—vaginal cancer	0.000122	0.00246	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EIF4A3—vaginal cancer	0.00012	0.00243	CbGpPWpGaD
Sunitinib—IRAK4—Innate Immune System—IFNA1—vaginal cancer	0.00012	0.00242	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EIF4A3—vaginal cancer	0.000119	0.0024	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling by Interleukins—IL2—vaginal cancer	0.000118	0.00239	CbGpPWpGaD
Sunitinib—KIT—female gonad—vaginal cancer	0.000117	0.000699	CbGeAlD
Sunitinib—MAP2K2—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000116	0.00236	CbGpPWpGaD
Sunitinib—KIT—Immune System—EIF4A3—vaginal cancer	0.000116	0.00236	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EIF4A3—vaginal cancer	0.000116	0.00236	CbGpPWpGaD
Sunitinib—RPS6KA3—Innate Immune System—IFNA1—vaginal cancer	0.000116	0.00235	CbGpPWpGaD
Sunitinib—KIT—vagina—vaginal cancer	0.000116	0.000694	CbGeAlD
Sunitinib—FGR—Hemostasis—IFNA1—vaginal cancer	0.000115	0.00233	CbGpPWpGaD
Sunitinib—ITK—Immune System—IFNA1—vaginal cancer	0.000115	0.00233	CbGpPWpGaD
Sunitinib—PDGFRB—female gonad—vaginal cancer	0.000114	0.000682	CbGeAlD
Sunitinib—PDGFRB—vagina—vaginal cancer	0.000113	0.000678	CbGeAlD
Sunitinib—ABCC4—uterus—vaginal cancer	0.000111	0.000664	CbGeAlD
Sunitinib—FGFR1—Immune System—EIF4A3—vaginal cancer	0.00011	0.00224	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EIF4A3—vaginal cancer	0.00011	0.00223	CbGpPWpGaD
Sunitinib—MAP2K1—Corticotropin-releasing hormone—IL2—vaginal cancer	0.00011	0.00222	CbGpPWpGaD
Sunitinib—PAK3—Immune System—IFNA1—vaginal cancer	0.00011	0.00222	CbGpPWpGaD
Sunitinib—FYN—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.00011	0.00222	CbGpPWpGaD
Sunitinib—MAP2K1—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000109	0.0022	CbGpPWpGaD
Sunitinib—KCNH2—uterine cervix—vaginal cancer	0.000106	0.000632	CbGeAlD
Sunitinib—JAK2—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000104	0.00211	CbGpPWpGaD
Sunitinib—FGR—Innate Immune System—IFNA1—vaginal cancer	0.000104	0.0021	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by Interleukins—IL2—vaginal cancer	0.000103	0.00209	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EIF4A3—vaginal cancer	0.000102	0.00206	CbGpPWpGaD
Sunitinib—ABCC4—female reproductive system—vaginal cancer	9.97e-05	0.000597	CbGeAlD
Sunitinib—PDGFRB—Immune System—EIF4A3—vaginal cancer	9.93e-05	0.00201	CbGpPWpGaD
Sunitinib—CAMK2G—Cytokine Signaling in Immune system—IL2—vaginal cancer	9.71e-05	0.00196	CbGpPWpGaD
Sunitinib—FYN—Signaling by Interleukins—IL2—vaginal cancer	9.71e-05	0.00196	CbGpPWpGaD
Sunitinib—KCNH2—urethra—vaginal cancer	9.7e-05	0.000581	CbGeAlD
Sunitinib—MAP2K1—Signaling by Interleukins—IL2—vaginal cancer	9.65e-05	0.00195	CbGpPWpGaD
Sunitinib—ABCC2—female reproductive system—vaginal cancer	9.65e-05	0.000578	CbGeAlD
Sunitinib—FYN—Immune System—EIF4A3—vaginal cancer	9.57e-05	0.00194	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—IFNA1—vaginal cancer	9.56e-05	0.00193	CbGpPWpGaD
Sunitinib—KCNH2—endometrium—vaginal cancer	9.55e-05	0.000572	CbGeAlD
Sunitinib—MAP2K1—Immune System—EIF4A3—vaginal cancer	9.52e-05	0.00193	CbGpPWpGaD
Sunitinib—MAP3K3—Cytokine Signaling in Immune system—IL2—vaginal cancer	9.48e-05	0.00192	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—IFNA1—vaginal cancer	9.46e-05	0.00191	CbGpPWpGaD
Sunitinib—ABCG2—uterine cervix—vaginal cancer	9.39e-05	0.000563	CbGeAlD
Sunitinib—YES1—Hemostasis—IFNA1—vaginal cancer	9.29e-05	0.00188	CbGpPWpGaD
Sunitinib—JAK2—Signaling by Interleukins—IL2—vaginal cancer	9.23e-05	0.00187	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EIF4A3—vaginal cancer	9.1e-05	0.00184	CbGpPWpGaD
Sunitinib—ABCC4—female gonad—vaginal cancer	9.07e-05	0.000543	CbGeAlD
Sunitinib—IRAK4—Cytokine Signaling in Immune system—IL2—vaginal cancer	8.82e-05	0.00178	CbGpPWpGaD
Sunitinib—KCNH2—uterus—vaginal cancer	8.8e-05	0.000527	CbGeAlD
Sunitinib—CYP3A5—uterine cervix—vaginal cancer	8.72e-05	0.000522	CbGeAlD
Sunitinib—ABCG2—urethra—vaginal cancer	8.63e-05	0.000517	CbGeAlD
Sunitinib—RPS6KA1—Immune System—IFNA1—vaginal cancer	8.5e-05	0.00172	CbGpPWpGaD
Sunitinib—ABCG2—endometrium—vaginal cancer	8.5e-05	0.000509	CbGeAlD
Sunitinib—YES1—Innate Immune System—IFNA1—vaginal cancer	8.37e-05	0.00169	CbGpPWpGaD
Sunitinib—ABCG2—mammalian vulva—vaginal cancer	8.22e-05	0.000492	CbGeAlD
Sunitinib—IRAK1—Innate Immune System—IFNA1—vaginal cancer	7.94e-05	0.00161	CbGpPWpGaD
Sunitinib—KCNH2—female reproductive system—vaginal cancer	7.91e-05	0.000474	CbGeAlD
Sunitinib—PTK2B—Cytokine Signaling in Immune system—IL2—vaginal cancer	7.86e-05	0.00159	CbGpPWpGaD
Sunitinib—ABCG2—uterus—vaginal cancer	7.83e-05	0.000469	CbGeAlD
Sunitinib—TBK1—Immune System—IFNA1—vaginal cancer	7.81e-05	0.00158	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—IFNA1—vaginal cancer	7.7e-05	0.00156	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—IFNA1—vaginal cancer	7.67e-05	0.00155	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—IFNA1—vaginal cancer	7.61e-05	0.00154	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—IFNA1—vaginal cancer	7.5e-05	0.00152	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IFNA1—vaginal cancer	7.49e-05	0.00152	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—IFNA1—vaginal cancer	7.47e-05	0.00151	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—IFNA1—vaginal cancer	7.47e-05	0.00151	CbGpPWpGaD
Sunitinib—KCNH2—female gonad—vaginal cancer	7.2e-05	0.000431	CbGeAlD
Sunitinib—KCNH2—vagina—vaginal cancer	7.16e-05	0.000429	CbGeAlD
Sunitinib—FGFR1—Innate Immune System—IFNA1—vaginal cancer	7.09e-05	0.00143	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—IFNA1—vaginal cancer	7.07e-05	0.00143	CbGpPWpGaD
Sunitinib—LATS2—Signaling Pathways—IL2—vaginal cancer	7.06e-05	0.00143	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IFNA1—vaginal cancer	6.96e-05	0.00141	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—IFNA1—vaginal cancer	6.82e-05	0.00138	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IFNA1—vaginal cancer	6.77e-05	0.00137	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IFNA1—vaginal cancer	6.53e-05	0.00132	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—IFNA1—vaginal cancer	6.49e-05	0.00131	CbGpPWpGaD
Sunitinib—ABCG2—female gonad—vaginal cancer	6.4e-05	0.000384	CbGeAlD
Sunitinib—PDGFRB—Innate Immune System—IFNA1—vaginal cancer	6.37e-05	0.00129	CbGpPWpGaD
Sunitinib—ABCG2—vagina—vaginal cancer	6.37e-05	0.000381	CbGeAlD
Sunitinib—PTK2B—Immune System—IFNA1—vaginal cancer	6.21e-05	0.00126	CbGpPWpGaD
Sunitinib—YES1—Cytokine Signaling in Immune system—IL2—vaginal cancer	6.17e-05	0.00125	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IFNA1—vaginal cancer	6.14e-05	0.00124	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IFNA1—vaginal cancer	6.11e-05	0.00124	CbGpPWpGaD
Sunitinib—BLK—Immune System—IFNA1—vaginal cancer	6.06e-05	0.00123	CbGpPWpGaD
Sunitinib—FGR—Immune System—IFNA1—vaginal cancer	6.04e-05	0.00122	CbGpPWpGaD
Sunitinib—ABCC4—Platelet activation, signaling and aggregation—IL2—vaginal cancer	6.02e-05	0.00122	CbGpPWpGaD
Sunitinib—CYP3A5—female gonad—vaginal cancer	5.94e-05	0.000356	CbGeAlD
Sunitinib—CYP3A5—vagina—vaginal cancer	5.91e-05	0.000354	CbGeAlD
Sunitinib—IRAK1—Cytokine Signaling in Immune system—IL2—vaginal cancer	5.85e-05	0.00118	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IFNA1—vaginal cancer	5.84e-05	0.00118	CbGpPWpGaD
Sunitinib—TYK2—Cytokine Signaling in Immune system—IL2—vaginal cancer	5.68e-05	0.00115	CbGpPWpGaD
Sunitinib—MAP3K7—Cytokine Signaling in Immune system—IL2—vaginal cancer	5.51e-05	0.00111	CbGpPWpGaD
Sunitinib—FYN—Platelet activation, signaling and aggregation—IL2—vaginal cancer	5.47e-05	0.00111	CbGpPWpGaD
Sunitinib—ABCB1—Allograft Rejection—IL2—vaginal cancer	5.44e-05	0.0011	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—IL2—vaginal cancer	5.35e-05	0.00108	CbGpPWpGaD
Sunitinib—JAK2—Platelet activation, signaling and aggregation—IL2—vaginal cancer	5.2e-05	0.00105	CbGpPWpGaD
Sunitinib—CYP3A4—female reproductive system—vaginal cancer	4.9e-05	0.000294	CbGeAlD
Sunitinib—YES1—Immune System—IFNA1—vaginal cancer	4.87e-05	0.000986	CbGpPWpGaD
Sunitinib—MAP2K2—Cytokine Signaling in Immune system—IL2—vaginal cancer	4.82e-05	0.000974	CbGpPWpGaD
Sunitinib—FGR—Hemostasis—IL2—vaginal cancer	4.76e-05	0.000963	CbGpPWpGaD
Sunitinib—ITK—Immune System—IL2—vaginal cancer	4.75e-05	0.000962	CbGpPWpGaD
Sunitinib—ABCB1—epithelium—vaginal cancer	4.67e-05	0.00028	CbGeAlD
Sunitinib—ABCB1—uterine cervix—vaginal cancer	4.63e-05	0.000277	CbGeAlD
Sunitinib—IRAK1—Immune System—IFNA1—vaginal cancer	4.62e-05	0.000935	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—IL2—vaginal cancer	4.55e-05	0.00092	CbGpPWpGaD
Sunitinib—PAK3—Immune System—IL2—vaginal cancer	4.53e-05	0.000917	CbGpPWpGaD
Sunitinib—FYN—Cytokine Signaling in Immune system—IL2—vaginal cancer	4.53e-05	0.000916	CbGpPWpGaD
Sunitinib—MAP2K1—Cytokine Signaling in Immune system—IL2—vaginal cancer	4.51e-05	0.000912	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IFNA1—vaginal cancer	4.49e-05	0.000908	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IFNA1—vaginal cancer	4.43e-05	0.000897	CbGpPWpGaD
Sunitinib—KIT—Immune System—IFNA1—vaginal cancer	4.35e-05	0.000881	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IFNA1—vaginal cancer	4.35e-05	0.000881	CbGpPWpGaD
Sunitinib—JAK2—Cytokine Signaling in Immune system—IL2—vaginal cancer	4.31e-05	0.000871	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—IL2—vaginal cancer	4.28e-05	0.000867	CbGpPWpGaD
Sunitinib—ABCB1—urethra—vaginal cancer	4.26e-05	0.000255	CbGeAlD
Sunitinib—ABCB1—endometrium—vaginal cancer	4.19e-05	0.000251	CbGeAlD
Sunitinib—FGFR1—Immune System—IFNA1—vaginal cancer	4.13e-05	0.000836	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IFNA1—vaginal cancer	4.12e-05	0.000834	CbGpPWpGaD
Sunitinib—ABCB1—mammalian vulva—vaginal cancer	4.05e-05	0.000243	CbGeAlD
Sunitinib—RPS6KA5—Immune System—IL2—vaginal cancer	3.95e-05	0.0008	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—IL2—vaginal cancer	3.91e-05	0.000792	CbGpPWpGaD
Sunitinib—ABCB1—uterus—vaginal cancer	3.86e-05	0.000231	CbGeAlD
Sunitinib—RPS6KA1—Signaling by GPCR—IL2—vaginal cancer	3.85e-05	0.000779	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—IL2—vaginal cancer	3.84e-05	0.000778	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—IL2—vaginal cancer	3.81e-05	0.000771	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—IL2—vaginal cancer	3.81e-05	0.000771	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IFNA1—vaginal cancer	3.8e-05	0.00077	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IFNA1—vaginal cancer	3.71e-05	0.000751	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—IL2—vaginal cancer	3.61e-05	0.000731	CbGpPWpGaD
Sunitinib—FYN—Immune System—IFNA1—vaginal cancer	3.58e-05	0.000724	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IFNA1—vaginal cancer	3.56e-05	0.00072	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—IL2—vaginal cancer	3.52e-05	0.000711	CbGpPWpGaD
Sunitinib—ABCB1—female reproductive system—vaginal cancer	3.47e-05	0.000208	CbGeAlD
Sunitinib—JAK2—Immune System—IFNA1—vaginal cancer	3.4e-05	0.000688	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—IL2—vaginal cancer	3.31e-05	0.000669	CbGpPWpGaD
Sunitinib—TBK1—Immune System—IL2—vaginal cancer	3.23e-05	0.000654	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—IL2—vaginal cancer	3.18e-05	0.000644	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—IL2—vaginal cancer	3.17e-05	0.000642	CbGpPWpGaD
Sunitinib—ABCB1—female gonad—vaginal cancer	3.16e-05	0.000189	CbGeAlD
Sunitinib—ABCB1—vagina—vaginal cancer	3.14e-05	0.000188	CbGeAlD
Sunitinib—ABCC4—Hemostasis—IL2—vaginal cancer	3.1e-05	0.000628	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IL2—vaginal cancer	3.1e-05	0.000627	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—IL2—vaginal cancer	3.07e-05	0.00062	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IL2—vaginal cancer	3.02e-05	0.000612	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IL2—vaginal cancer	3.02e-05	0.000612	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—IL2—vaginal cancer	2.98e-05	0.000603	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL2—vaginal cancer	2.93e-05	0.000593	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL2—vaginal cancer	2.88e-05	0.000583	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—IL2—vaginal cancer	2.82e-05	0.000571	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL2—vaginal cancer	2.8e-05	0.000567	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL2—vaginal cancer	2.71e-05	0.000547	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL2—vaginal cancer	2.71e-05	0.000547	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—IL2—vaginal cancer	2.68e-05	0.000543	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL2—vaginal cancer	2.57e-05	0.000519	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL2—vaginal cancer	2.56e-05	0.000517	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL2—vaginal cancer	2.53e-05	0.000512	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL2—vaginal cancer	2.51e-05	0.000507	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL2—vaginal cancer	2.5e-05	0.000505	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL2—vaginal cancer	2.41e-05	0.000488	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL2—vaginal cancer	2.27e-05	0.00046	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL2—vaginal cancer	2.26e-05	0.000456	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL2—vaginal cancer	2.03e-05	0.000411	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL2—vaginal cancer	2.02e-05	0.000408	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL2—vaginal cancer	1.95e-05	0.000394	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL2—vaginal cancer	1.91e-05	0.000387	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL2—vaginal cancer	1.86e-05	0.000375	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL2—vaginal cancer	1.83e-05	0.000371	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL2—vaginal cancer	1.83e-05	0.00037	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL2—vaginal cancer	1.81e-05	0.000366	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL2—vaginal cancer	1.8e-05	0.000364	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL2—vaginal cancer	1.8e-05	0.000364	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL2—vaginal cancer	1.72e-05	0.000348	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL2—vaginal cancer	1.71e-05	0.000346	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL2—vaginal cancer	1.7e-05	0.000345	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—IL2—vaginal cancer	1.69e-05	0.000343	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL2—vaginal cancer	1.66e-05	0.000336	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL2—vaginal cancer	1.61e-05	0.000326	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL2—vaginal cancer	1.6e-05	0.000323	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL2—vaginal cancer	1.59e-05	0.000321	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL2—vaginal cancer	1.57e-05	0.000318	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL2—vaginal cancer	1.54e-05	0.000312	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL2—vaginal cancer	1.54e-05	0.000312	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL2—vaginal cancer	1.54e-05	0.000311	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL2—vaginal cancer	1.53e-05	0.000311	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL2—vaginal cancer	1.5e-05	0.000304	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL2—vaginal cancer	1.48e-05	0.000299	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL2—vaginal cancer	1.47e-05	0.000298	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL2—vaginal cancer	1.41e-05	0.000285	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL2—vaginal cancer	1.3e-05	0.000264	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL2—vaginal cancer	1.24e-05	0.00025	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL2—vaginal cancer	1.2e-05	0.000243	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL2—vaginal cancer	1.18e-05	0.00024	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL2—vaginal cancer	1.16e-05	0.000235	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL2—vaginal cancer	1.16e-05	0.000235	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—vaginal cancer	1.1e-05	0.000223	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—vaginal cancer	1.1e-05	0.000223	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—vaginal cancer	1.02e-05	0.000206	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—vaginal cancer	9.92e-06	0.000201	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—vaginal cancer	9.56e-06	0.000194	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—vaginal cancer	9.51e-06	0.000192	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—vaginal cancer	9.09e-06	0.000184	CbGpPWpGaD
